LERCANIDIPINE TEVA 10 MG

국가: 이스라엘

언어: 영어

출처: Ministry of Health

지금 구매하세요

환자 정보 전단 환자 정보 전단 (PIL)
30-04-2017

유효 성분:

LERCANIDIPINE HYDROCHLORIDE

제공처:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATC 코드:

C08CA13

약제 형태:

TABLETS

구성:

LERCANIDIPINE HYDROCHLORIDE 10 MG

관리 경로:

PER OS

처방전 유형:

Required

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

치료 영역:

LERCANIDIPINE

치료 징후:

Mild to moderate essential hypertension.

승인 날짜:

2016-09-30

환자 정보 전단

                                PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicine is dispensed with a
doctor’s prescription only
LERCANIDIPINE TEVA
®
10 MG
TABLETS
The active ingredient and its
quantity:
Each tablet contains:
Lercanidipine hydrochloride 10 mg
LERCANIDIPINE TEVA
®
20 MG
TABLETS
The active ingredient and its
quantity:
Each tablet contains:
Lercanidipine hydrochloride 20 mg
For the list of inactive ingredients,
please see section 6.
READ THIS LEAFLET CAREFULLY IN ITS
ENTIRETY BEFORE USING THE MEDICINE.
This
leaflet
contains
concise
information about the medicine. If
you have further questions, refer to
the doctor or pharmacist.
This medicine has been prescribed
to treat your ailment. Do not pass it
on to others. It may harm them even
if it seems to you that their ailment
is similar.
The medicine is not intended for use
in children under 18 years of age.
1. WHAT
IS
THE
MEDICINE
INTENDED FOR?
For the treatment of mild to moderate
hypertension.
THERAPEUTIC GROUP:
Calcium channel blockers of the
dihydropyridine group.
2. B E F O R E
U S I N G
T H E
MEDICINE
DO NOT USE THE MEDICINE IF:
∙ You are pregnant or breastfeeding,
think you are pregnant, are
planning a pregnancy or do not
use contraceptives.
∙ You are sensitive (allergic) to
the active ingredient or to any
of the other ingredients of the
medicine (see section 6), or to
other medicines from this group,
such as: amlodipine, nicardipine,
felodipine, isradipine, nifedipine
or lacidipine.
∙ You suffer from certain heart
diseases, such as: uncontrolled
heart failure, an obstruction
of blood flow from the heart,
unstable angina (angina at rest
or which gradually increases),
or within one month of a heart
attack.
∙ You suffer from a severe liver or
kidney disease.
∙ You are concomitantly taking:
cyclosporine,
antifungal
medicines, such as ketoconazole
or
itraconazole,
macrolide
antibiotics such as erythromycin
or troleandomycin, antiviral
medicines such as ritonavir.
∙ You consume grapefruits or
grapefruit juice.
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 아랍어 30-04-2017
환자 정보 전단 환자 정보 전단 히브리어 08-01-2017

이 제품과 관련된 검색 알림